B. Zinman
Endocrinology, Diabetes and Metabolism · 2001–2019
A researcher in the Science corpus: 21 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Endocrinology, Diabetes and Metabolism — 198 citations into it; #254 of 623 by trust here, #22 by citations
- Statistics and Probability — 7 citations into it
Whom B. Zinman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Zinman overall
Papers from B. Zinman's perspective
Ordered by how strongly the researchers B. Zinman trusts endorse each paper. Same corpus, a different order for every researcher.
- Measuring inconsistency in meta-analyses (British medical journal)
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
- Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. (Cochrane Database of Systematic Reviews)
- Uric acid and cardiovascular risk. (New England Journal of Medicine)
- Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations (Circulation)
- Explanation in causal inference: Methods for mediation and interaction.
- Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes (Diabetes, obesity and metabolism)
- Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (Diabetes Care)
- Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. (Diabetes Care)
Their papers
- Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2006) — 954 citations
- Impaired Fasting Glucose and Impaired Glucose Tolerance (2007) — 939 citations
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) — 2,670 citations
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. (2006) — 1,710 citations
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. (2019) — 4,852 citations
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial (2019) — 968 citations
- How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial (2017) — 631 citations
- Effects of Once‐Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes (2017) — 1,746 citations
- Liraglutide and Renal Outcomes in Type 2 Diabetes (2017) — 656 citations
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. (2016) — 3,043 citations
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial (2016) — 905 citations
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. (2015) — 5,975 citations
- Are Metabolically Healthy Overweight and Obesity Benign Conditions? (2013) — 891 citations
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) (2009) — 858 citations
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes (2009) — 686 citations
- Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years’ Duration (2009) — 648 citations
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes (2009) — 2,915 citations
- Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008) — 751 citations
- Prevention or delay of type 2 diabetes. (2004) — 703 citations
- Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. (2003) — 880 citations